Clinical Trial Update: A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the efficacy of LT-02 in patients with mesalazine-refractory ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LT-02

Snippet

Sponsor: Lipid Therapeutics GmbH | Conditions: Ulcerative Colitis, Large Intestine | Phase 2 | Status: UNKNOWN